Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00525772 | Effect of Ciclesonide on Exercise Induced Bronchoconstriction | PHASE3 | COMPLETED | 26 | — | — | Nov 1, 2001 | Nov 1, 2007 | Oct 21, 2009 | 1 | Canada |
| Arm | Type | Description |
|---|---|---|
| 1 | ACTIVE_COMPARATOR | ciclesonide 50 and 200ug |
| 2 | ACTIVE_COMPARATOR | ciclesonide 100ug and 400ug |
| Name | Type | Description |
|---|---|---|
| ciclesonide | DRUG | low dose- 50ug and 200ug |
Inclusion Criteria: * stable asthma not on maintenance asthma medications * exercise induced bronchoconstriction on dry air exercise challenge. Exclusion Criteria: * other significant co-morbidity or treatments that might interfere with the conduct or results of the study * fail to return to base...